Log In
Print
BCIQ
Print
Print this Print this
 

ISIS-ANGTPL3Rx

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionAntisense inhibitor of angiopoietin-like 3 (ANGPTL3)
Molecular Target Angiopoietin-like 3 (ANGPTL3)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I
Standard IndicationHyperlipidemia
Indication DetailsTreat hyperlipidemia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today